Abstract: Described herein are systems, methods, and software to manage power consumption in a software build environment. In one implementation, a monitoring service monitors power consumption information associated with a build environment for one or more software components. The monitoring service further identifies one or more trends associated with the power consumption information based at least on the power consumption information satisfying one or more criteria and generates a summary for display that indicates at least the one or more trends. The monitoring service may also identify and display as part of the summary one or more suggestions to improve power consumption based on the one or more trends.

Abstract: Described herein are systems, methods, and software to manage power consumption in a software build environment. In one implementation, a monitoring service monitors power consumption information associated with a build environment for one or more software components. The monitoring service further identifies one or more trends associated with the power consumption information based at least on the power consumption information satisfying one or more criteria and generates a summary for display that indicates at least the one or more trends. The monitoring service may also identify and display as part of the summary one or more suggestions to improve power consumption based on the one or more trends.

Abstract: A method of inhibiting neuroinflammation in neuron surrounding cells, includes a step of treating the neuron surrounding cells with at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor or a combination thereof, to inhibit the neuroinflammation. A method of managing neuroinflammation or neuroinflammation mediated neurodegenerative disease or disorder in a subject in need thereof, includes administering at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor or a combination thereof to the subject. A composition includes at least one tyrosine kinase inhibitor or at least one sirtuin-2 inhibitor optionally along with pharmaceutically acceptable excipient.

Abstract: A method of inhibiting neuroinflammation in neuron surrounding cells, includes a step of treating the neuron surrounding cells with at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor or a combination thereof, to inhibit the neuroinflammation. A method of managing neuroinflammation or neuroinflammation mediated neurodegenerative disease or disorder in a subject in need thereof, includes administering at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor or a combination thereof to the subject. A composition includes at least one tyrosine kinase inhibitor or at least one sirtuin-2 inhibitor optionally along with pharmaceutically acceptable excipient.